Embracing Innovation: Transforming Hyperbilirubinemia Management with CoSense ETCOc Technology. The CoSense® ETCOc Monitor performs a non-invasive, bedside breath test using a nasal cannula, and identifies hemolysis and neurotoxic risks from rising unconjugated bilirubin, aiming to prevent hemolytic HB and Kernicterus. Grounded in extensive research, peer-reviewed studies, and neonatology expert endorsements, CoSense® revolutionizes neonatal care by enabling precise, customized interventions, including vigilant monitoring and effective phototherapy, setting new care standards in neonatology.